Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2025-02-11 | "From 2019 to 2023, Dr. Audoly was the Founder, CEO, President, Chief Scientific Officer of Parthenon Therapeutics, a biotech company operating at the intersection of systems biology, machine learning, molecular pharmacology, and drug development..." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25